Aluminium Hydroxide/LHD153R adjuvanted Meningococcal C-CRM197 conjugate vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aluminium Hydroxide/LHD153R adjuvanted Meningococcal C-CRM197 conjugate vaccine, covering 2019-06-07 to 2019-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine [Phase 1]